Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Potential role of biventricular pacing beyond advanced systolic heart failure.

Fang F, Sanderson JE, Yu CM.

Circ J. 2013;77(6):1364-9. Review.

2.

Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.

Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN.

Europace. 2015 Feb;17(2):267-73. doi: 10.1093/europace/euu214. Review.

PMID:
25164431
3.

The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.

Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.

Pacing Clin Electrophysiol. 2007 Feb;30(2):193-8.

PMID:
17338715
4.

Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

Gold MR, Thébault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC.

Circulation. 2012 Aug 14;126(7):822-9. doi: 10.1161/CIRCULATIONAHA.112.097709.

5.

Will biventricular pacing replace right ventricular pacing for antibradycardia therapy?

Barold SS, Herweg B.

Expert Rev Med Devices. 2013 Sep;10(5):591-6. doi: 10.1586/17434440.2013.835552.

PMID:
24053252
6.

Expanding indications for resynchronization therapy.

Leclercq C, Behar N, Mabo P, Daubert JC.

Curr Cardiol Rep. 2012 Oct;14(5):540-6. doi: 10.1007/s11886-012-0299-1.

PMID:
22843449
7.

Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.

Zusterzeel R, Selzman KA, Sanders WE, Caños DA, O'Callaghan KM, Carpenter JL, Piña IL, Strauss DG.

JAMA Intern Med. 2014 Aug;174(8):1340-8. doi: 10.1001/jamainternmed.2014.2717.

PMID:
25090172
8.

Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.

Rönn F, Kesek M, Karp K, Henein M, Jensen SM.

Europace. 2011 Dec;13(12):1747-52. doi: 10.1093/europace/eur193.

PMID:
21712261
9.

QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.

Brenyo A, Rao M, Barsheshet A, Cannom D, Quesada A, McNitt S, Huang DT, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2013 Apr;24(4):442-8. doi: 10.1111/jce.12057.

PMID:
23252875
10.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.

J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.

PMID:
18226768
11.

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.

Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J; EchoCRT Study Group..

N Engl J Med. 2013 Oct 10;369(15):1395-405. doi: 10.1056/NEJMoa1306687.

12.

Recent advances in cardiac resynchronization therapy.

Steffel J, Holzmeister J, Abraham WT.

Postgrad Med. 2011 Mar;123(2):18-26. doi: 10.3810/pgm.2011.03.2259. Review.

PMID:
21474889
13.

Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.

Santangeli P, Di Biase L, Pelargonio G, Dello Russo A, Casella M, Bartoletti S, Burkhardt JD, Mohanty P, Santarelli P, Natale A.

J Interv Card Electrophysiol. 2011 Nov;32(2):125-35. doi: 10.1007/s10840-011-9584-y. Review.

PMID:
21594629
14.

Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).

Birnie DH, Ha A, Higginson L, Sidhu K, Green M, Philippon F, Thibault B, Wells G, Tang A.

Circ Heart Fail. 2013 Nov;6(6):1190-8. doi: 10.1161/CIRCHEARTFAILURE.113.000380.

15.

Electrical devices for left ventricular dysfunction and heart failure: do we need revised guidelines?

Guglin M, Barold SS.

J Interv Card Electrophysiol. 2012 Aug;34(2):197-204. doi: 10.1007/s10840-011-9639-0.

PMID:
22173864
16.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group..

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027.

17.

Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.

Freeman JV, Masoudi FA.

Heart Fail Clin. 2013 Jan;9(1):59-77. doi: 10.1016/j.hfc.2012.09.006. Review.

PMID:
23168318
18.
19.

Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.

Rickard J, Bassiouny M, Cronin EM, Martin DO, Varma N, Niebauer MJ, Tchou PJ, Tang WH, Wilkoff BL.

Am J Cardiol. 2011 Dec 1;108(11):1576-80. doi: 10.1016/j.amjcard.2011.07.017.

PMID:
21890086
20.

Cardiac resynchronization therapy: device-based medicine for heart failure.

Philippon F.

J Card Surg. 2004 May-Jun;19(3):270-4. Review.

PMID:
15151661

Supplemental Content

Support Center